Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SPX Technologies (SPXC) Cash & Equivalents (2016 - 2025)

SPX Technologies (SPXC) has 17 years of Cash & Equivalents data on record, last reported at $364.0 million in Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 131.99% year-over-year to $364.0 million; the TTM value through Dec 2025 reached $364.0 million, up 131.99%, while the annual FY2025 figure was $364.0 million, 131.99% up from the prior year.
  • Cash & Equivalents reached $364.0 million in Q4 2025 per SPXC's latest filing, up from $229.4 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $553.7 million in Q4 2021 and bottomed at $50.3 million in Q3 2021.
  • Average Cash & Equivalents over 5 years is $188.7 million, with a median of $152.4 million recorded in 2022.
  • The widest YoY moves for Cash & Equivalents: up 683.17% in 2021, down 73.55% in 2021.
  • A 5-year view of Cash & Equivalents shows it stood at $388.2 million in 2021, then tumbled by 61.93% to $147.8 million in 2022, then plummeted by 32.75% to $99.4 million in 2023, then skyrocketed by 57.85% to $156.9 million in 2024, then skyrocketed by 131.99% to $364.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $364.0 million in Q4 2025, $229.4 million in Q3 2025, and $132.8 million in Q2 2025.